The tweet was deleted by the author.
But we saved everything 🙂.
Patrick Soon-Shiong, a renowned healthcare entrepreneur, has announced the opening of a trial for Bioshield, aimed at exploring treatments for long Covid.
Interested parties are encouraged to submit their enquiries through the designated form provided in the announcement. The trial signifies a significant step towards addressing the growing concerns surrounding long Covid, which has continued to impact many individuals globally. Soon-Shiong has emphasized the importance of this trial in advancing treatment options for affected patients. The Bioshield research is linked with the hashtag #anktiva, indicating its potential relevance in therapeutic development.
Soon-Shiong’s dedication to advancing patient care through innovative research has long been evident, reflecting broader themes explored in his discussions regarding healthcare priorities with Senator Bill Cassidy and an unwavering focus on patient and national welfare. Further context on these initiatives can be found in his analysis of healthcare commitment.